Gustavo Morales, Executive Director of the Association of Pharmaceutical Research and Development Laboratories (AFIDRO) and proud advocate of intellectual property has successfully changed Colombian public opinion on the pharmaceutical industry. In this interview, Gustavo explains how recent regulations will increase the demand of pharmaceutical products as well as the incentives needed in order to resolve inefficiencies, fraud, and corruption.
Mr. Morales, in our last interview in 2013, your predecessor, Francisco Paula de Gomez, concluded with the sentiment that there should be a focus on maintaining the equilibrium of the healthcare system and regulating pricing. Since your appointment in October 2015, what has been the key advancements in these areas?
"What matters most to AFIDRO and every stakeholder is that the regulation is applied in a systemic, predictable way."
